Oral bacteria-combined intranasal vaccine protects from influenza A virus and SARS-CoV-2 infection

Minami Nagai

[P-004] Oral bacteria-combined intranasal vaccine protects from influenza A virus and SARS-CoV-2 infection

^○Minami Nagai¹, Moriyama Miyu², Ichinohe Takeshi¹ (1.Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2.Yale University School of Medicine, CT, USA)

Abstract password authentication.
You need a password to log in to the dedicated site for participants where you can browse abstracts, view e-posters and deliver an online presentation with Zoom meeting.
The forum secretariat will send the password to those who completed the registration on Tuesday, September 21 (tentative) via email.

Presentation information

[Poster Session 2] Viral Infections

[P-004] Oral bacteria-combined intranasal vaccine protects from influenza A virus and SARS-CoV-2 infection

Password